Billev Pharma ApS

Private limited companyCVR 81814813HørsholmActive

Billev Pharma ApS is a private limited company, based in Hørsholm, active in other professional, scientific and technical activities n.e.c., founded in 1977. Net profit rose 66% from 2025 to 2026, ending at DKK 10.2m. Measured by gross profit, it ranks no. 9 of 309 companies in the industry in the database. Profit has grown three years in a row.

Follow
PDF reportCompare

Key figures · financial year 2026

Gross profitDKK 38.8m+24.4% vs. 2025
Net profitDKK 10.2m+66.1% vs. 2025
EquityDKK 10.5m+62.8% vs. 2025
Employees28latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2026 against 2025

  • Gross profit rose 24% (2025 → 2026), to DKK 38.8m.
  • Net profit rose 66% (2025 → 2026), to DKK 10.2m.
  • Equity rose 63% (2025 → 2026), to DKK 10.5m.

Employees

  • 4 more employees than a year earlier: 28 (07/2026) against 24 (07/2025).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2021–2026 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 2mDKK 4mDKK 6mDKK 8mDKK 10m202120222023202420252026
EquityNet profit
Financial figures for Billev Pharma ApS
202120222023202420252026Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit25,63830,17129,07324,76331,18938,801+24.4%
Operating profit (EBIT)7,1207,7616,3944,3577,92313,077+65%
Profit before tax7,1207,7216,3424,3427,90413,097+65.7%
Net profit5,5496,0134,9433,3796,14410,206+66.1%
Total assets9,36610,3628,9466,91112,28015,765+28.4%
Equity5,8696,3335,2633,6996,46410,526+62.8%
Liabilities3,3973,9123,5953,1395,7555,215−9.4%
Cash and cash equivalents2,0824,7273,8702,1875,1487,981+55%
Average number of employees192121192124+14.3%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025, 2026: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 5mDKK 10mDKK 15mDKK 20mDKK 25mDKK 30mDKK 35mDKK 40m202120222023202420252026
Gross profitMedian, the industry (310 companies)

Signals from the financial statements

calculated from the 2026 figures
  • Profit for five years in a row

    Net result has been positive in 2022–2026.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Billev Pharma ApS
Financial yearPeriodPublishedFigures forDocuments
202601/05/2025 – 30/04/202623/06/2026The companyPDF not statedXBRL
202501/05/2024 – 30/04/202527/06/2025The companyPDF not statedXBRL
202401/05/2023 – 30/04/202426/06/2024The companyPDFXBRL
202301/05/2022 – 30/04/202326/06/2023The companyPDFXBRL
202201/05/2021 – 30/04/202220/06/2022The companyPDFXBRL
202101/05/2020 – 30/04/202105/07/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
05101520253008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

310 companies in the database

Comparison with the other companies in other professional, scientific and technical activities n.e.c. based on the latest financial year.

Gross profitDKK 38.8mNo. 9 of 309
Better than 97% of the companies in the industry
EquityDKK 10.5mNo. 28 of 310
Better than 91% of the companies in the industry
Number of employees28No. 23 of 310
Better than 93% of the companies in the industry

Industry median: gross profit DKK 1.9m, net profit DKK 142k, equity DKK 1.1m, 2 employees.

DKK 100kDKK 708kDKK 5mDKK 35.5mDKK 130.8mHere
Distribution of gross profit for 278 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 20–49 employees9,922 companies in the comparison
No. 780of 9,892
Better than 92%
No. 2,982of 9,922
Better than 70%
Same industry and 20–49 employees19 companies in the comparison
No. 1of 19
Better than 100%
No. 3of 19
Better than 89%
Companies that are at least 30 years old10,276 companies in the comparison
No. 1,810of 10,152
Better than 82%
No. 4,660of 10,275
Better than 55%
All companies of type ApS66,508 companies in the comparison
No. 1,023of 66,379
Better than 98%
No. 6,625of 66,505
Better than 90%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Other professional, scientific and technical activities n.e.c.
Gross profit
  1. Billev Pharma ApSDKK 38.8m
  2. Clearwater Denmark K/SDKK 251.1m
  3. Bureau Veritas Denmark A/SDKK 149.1m
Net profit
  1. Billev Pharma ApSDKK 10.2m
  2. Clearwater Denmark K/SDKK 134.2m
  3. Bureau Veritas Denmark A/SDKK 17.3m
Equity
  1. Billev Pharma ApSDKK 10.5m
  2. Clearwater Denmark K/SDKK 76.4m
  3. Bureau Veritas Denmark A/SDKK 18.7m
Employees
  1. Billev Pharma ApS28
  2. Clearwater Denmark K/S56
  3. Bureau Veritas Denmark A/S161

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Van Arkens Holding ApS50%
  • Ul Jensen Holding ApS50%
Billev Pharma ApS

Management

2 active registrations

Executive management

Executive management at Billev Pharma ApS
NameRoleAppointed
Ulrikke Lynge JensenDirector30/04/2015
Anja Wencke van ArkensDirector30/04/2015
Former management (1)
Former management at Billev Pharma ApS
NameRoleAppointedResigned
Peter de Mayo BillevDirector22/07/197730/04/2015

Signing rule: Selskabet tegnes af den samlede direktion.

Address and production units

1 active production units

Slotsmarken 10
2970 Hørsholm

Hørsholm Municipality · Postcode 2970

Other companies at the address (2)

Production units
Production unitAddressEmployeesP number
BILLEV PHARMA ApSSlotsmarken 10, 2970 Hørsholm281002630089

Purpose

Selskabets formål er at drive famaceutisk-medicinsk- og lignende konsulent- og agenturvirksomhed, samt dermed i forbindelse såtende virksomhed

The purpose is quoted from the register in Danish.

Changes year by year

25 registered events
20261 changeaccounts 1
  • Annual report for 2026 published
20251 changeaccounts 1
  • Annual report for 2025 published
20241 changeaccounts 1
  • Annual report for 2024 published
20231 changeaccounts 1
  • Annual report for 2023 published
20221 changeaccounts 1
  • Annual report for 2022 published
20211 changeaccounts 1
  • Annual report for 2021 published
20165 changesownership 5
  • VAN ARKENS HOLDING ApS registered as owner (50%)
  • UL JENSEN HOLDING ApS registered as owner (50%)
  • VAN ARKENS HOLDING ApS is no longer registered as owner
  • UL JENSEN HOLDING ApS is no longer registered as owner
  • BILLEV HOLDING ApS is no longer registered as owner
20155 changesaddress 1 · management 3 · industry 1
  • Moved to Slotsmarken 10, 2970 Hørsholm
  • Ulrikke Lynge Jensen appointed director
  • Anja Wencke van Arkens appointed director
  • Peter de Mayo Billev stepped down as director
  • Industry changed to Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749090)
20115 changesownership 3 · capital 2
  • VAN ARKENS HOLDING ApS registered as owner (33.33%)
  • UL JENSEN HOLDING ApS registered as owner (33.33%)
  • Share capital changed from 80,000 DKK to 320,000 DKK
  • BILLEV HOLDING ApS registered as owner (25%)
  • Share capital changed from 200,000 DKK to 80,000 DKK
20071 changeaddress 1
  • Moved to Elmegårdsvej 1A, Tørslev, 3630 Jægerspris
19961 changecapital 1
  • Share capital changed from 80,000 DKK to 200,000 DKK
19772 changesfounded 1 · management 1
  • Registered as BILLEV PHARMA ApS
  • Peter de Mayo Billev appointed director

Related companies

Same industry in Hørsholm

See all →

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction